Adasuve launched in Europe for agitation in patients with schizophrenia or bipolar disorder Aug. 1, 2013
European Commission grants orphan drug designation to BrainStorm's cell therapy for ALS July 31, 2013
MK-8931 leads to reductions in brain amyloid levels in patients with Alzheimer's disease July 31, 2013
RSS